Yoshinobu Maeda

19PUBLICATIONS
98CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursPredictive and prognostic markersCancer cell biologyCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Jun 20, 2026
Association of ideal body weight-normalized post-transplantation cyclophosphamide dose with chronic GVHD in patients with overweight/obesity.

|May 18, 2026
Incidence of B-cell Malignancies in Patients with Lung Cancer Receiving PD-1 Blockade Therapy.

|Jan 13, 2026
Clinical Characteristics and Spatial Transcriptome Analysis of Non-Small Cell Lung Cancers Exhibiting Early Alectinib Resistance: A Retrospective OLCSG Study.

Tadahiro Kuribayashi, Go Makimoto, Kadoaki Ohashi

|Nov 26, 2025
Long-term follow-up of belumosudil as second or subsequent line of therapy for steroid-dependent/resistant cGVHD: clinical outcomes from a Japanese study.

Koji Kato, Yoshihiro Inamoto, Toshiro Kawakita

|Jul 01, 2025
Close Spatial Interactions between Cancer Cells and Cancer-Associated Fibroblasts Suppress Antitumor Immunity.

Yuto Naoi, Yumi Inukai, Tomoka Izumikawa

|May 29, 2025
Colony-Stimulating Factor-1 Receptor Inhibitor Augments Osimertinib-Induced Antitumor Immunity via Suppression of Macrophages in Lung Cancer Harboring EGFR Mutation.

Sachi Okawa, Shuta Tomida, Tadahiro Kuribayashi

Pageof 4

Frequent Collaborators

8 joint publications

Masaaki Yamagishi

7 joint publications

Hisayuki Hongu

5 joint publications

Shuhei Fujita

4 joint publications

Hitoshi Yaku